Stem Cell Network (SCN)
For More Information
The Stem Cell Network is pleased to launch a new national research funding competition consisting of four translational research programs in stem cell and regenerative medicine:
1. Accelerating Clinical Translation Program (Round 1 and 2)
The Accelerating Clinical Translation program supports multi-disciplinary research projects that are moving toward the clinic. This program will also support translational research activities (including ELSI questions) associated with an upcoming or ongoing clinical trial.
2. Fueling Biotechnology Partnerships Program (Round 1 and 2)
The Fueling Biotechnology Partnerships program supports academic partnerships with emerging Canadian regenerative medicine biotech companies who are working to drive an innovative stem cell-based technology or therapy into the clinic or market.
3. Advancing Clinical Trials Program (Round 1 only)
The Advancing Clinical Trials program supports early stage clinical trial projects with high translational potential. This program focuses on novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. The clinical trials within this program will be led by academics working in leading Canadian research institutions and will bring forward innovative therapies or technologies of potential value to the Canadian health care system.
4. Translation and Society Program (Round 1 and 2)
The Translation & Society program supports ethical, legal and social implications (ELSI) projects that that focus on impediments to progress in the translation of innovative stem cell research.
Please see the program-specific eligibility criteria in each program's Guidelines Document.
Together, $11 million will be made available through these peer-reviewed funding competitions to support Canadian stem cell research. Note: Funding is dependent on the completion of SCN’s 2019-22 contribution agreement with the Government of Canada.
Maximum Project Value
Award values vary across the four programs. Details can be found in the Guidelines for each program. The range starts at $75,000 and goes up to $1,000,000.
The first funding competition (Round 1) is for projects and clinical trials up to 25 months in length (January 1, 2020 – January 31, 2022). SCN anticipates that a second competition (Round 2) will be launched in early 2020.
SCN-funded projects require partner support (in-kind or financial). Eligible partners include industry, not-for-profit organizations, foundations, research institutions, health charities and provincial governments. Please note, federal funders (e.g. CIHR, NSERC, SSHRC, CFI, NCEs, Genome Canada, New Frontiers Research Fund, IRAP) are ineligible for matching.
If College-level review is required, your College will communicate its earlier internal deadlines.
How to Apply
Please visit the SCN website to download the applicable Guidelines Document, Application Form, Institutional/Investigator Signature Document, and Budget Template for the program you intend to apply for.
All applications must be emailed on or before the deadline to: Rebecca Cadwalader at firstname.lastname@example.org. A confirmation email will be sent within 48 hours of SCN receiving the submitted application package. If a confirmation email is NOT received from SCN within 48 hours of submission it is the responsibility of the lead applicant to contact SCN and ensure that the application package has been received.
Information For Co-applicants
If you need to meet a deadline set by the lead institution for this opportunity, please ensure that you provide the Office of Research with at least five days in advance of the lead institution’s deadline to review the application, or your proposed component of the project. Please be in touch with the Office of Research at email@example.com ahead of the deadline if it looks like it will be difficult for you to submit all the required documentation on time (i.e. budget, proposal, OR-5 Form).
|SCN Research Funding Program FAQs||281.4 KB|